Novartis loses a head honcho, with US oncology head Bill Hinshaw exiting for new gig at Axcella
Big Pharma has lost yet another top executive to the glossy ranks of small — but cash-rich — biotech, with Bill Hinshaw, the former head of US …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
